Scientists have identified three acidic cannabinoids in cannabis that reduces seizure activity in mouse models of Dravet syndrome.
Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
An imbalance in gut bacteria can cause the reduction of some metabolites, resulting in depression-like symptoms. The findings contribute to the growing body of evidence for the role the microbiome plays in brain function and mental health.
Disrupted cannabinoid signaling impairs learning by altering behavioral states.
Many cannabis users don't know how much THC or CBD is considered an effective dose.
Meta-analysis of previous studies reveals cannabinoid treatments produce a small, but significant reduction in subjective pain scores for sufferers of chronic pain.
37% of Millenials and 25% of Gen Xers say they have used cannabinoids to help relieve pain.
Study provides further evidence the endocannabinoid system plays a crucial role in obsessive-compulsive disorder (OCD). Using cannabinoid drugs have a positive impact in helping control behaviors associated with OCD.
Researchers provide the first cannabis chromosome map, revealing ancient viruses contributed to the evolution of marijuana.
Researchers report adolescent cannabis use alters the structural development of the prefrontal cortex, an area of the brain that helps control higher cognitive functions.
A new study explores the differences in cannabis use between males and females. Researchers reveal women are develop addiction to marijuana more quickly than men. The study reports females have different levels of endocannabinoids and more sensitive receptors than males in areas related to social behavior.
A new study reveals cannabinoid medications may not reduce pain itself, but instead make pain feel less unpleasant and more tolerable.
